Murchinson Ltd. Taro Pharmaceutical Industries LTD Transaction History

Murchinson Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $4.66 Million - $4.92 Million	-113,645 Reduced 67.73%	54,137 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $2.1 Million - $2.71 Million	64,038 Added 61.73%	167,782 $7.01 Million
Q2 2023 Aug 14, 2023	SELL	$24.24 - $40.97 $52,600 - $88,904	-2,170 Reduced 2.05%	103,744 $3.94 Million
Q4 2022 Feb 10, 2023	SELL	$27.6 - $32.99 $1.92 Million - $2.3 Million	-69,606 Reduced 39.66%	105,914 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$28.74 - $39.9 $57,480 - $79,800	2,000 Added 1.15%	175,520 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $378,595 - $471,513	10,817 Added 6.65%	173,520 $6.27 Million
Q1 2022 May 12, 2022	BUY	$43.12 - $50.3 $150,920 - $176,050	3,500 Added 2.2%	162,703 $7.04 Million
Q4 2021 Feb 14, 2022	BUY	$47.6 - $65.0 $2.82 Million - $3.85 Million	59,203 Added 59.2%	159,203 $7.98 Million
Q2 2021 Aug 13, 2021	BUY	$70.26 - $76.64 $7.03 Million - $7.66 Million	100,000 New	100,000 $7.2 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

Stay updated on Murchinson Ltd. with notifications on news.